The AI Advantage in Revolutionising Lab Quality Control

Imagine a lab where precision meets efficiency, and every operation is optimised to perfection. In the intricate world of laboratory operations, a silent revolution is underway – the integration of Artificial Intelligence (AI) to elevate the standards of quality control. A game-changer that holds the key to unlocking unparalleled advancements in scientific research and experimentation.


The crucial role of AI in lab quality control: Today and tomorrow

As laboratories grapple with increasing complexities in research and analysis, the importance of AI technology becomes increasingly apparent. AI is not just a futuristic concept; it is the present and the future of laboratory operations. Today, AI is being harnessed to enhance quality control practices by providing real-time monitoring, predictive analytics, and automated decision-making.

Looking ahead, AI is poised to become the cornerstone of innovation in labs, offering solutions to challenges that were once deemed insurmountable.


Benefits of using AI in lab quality control: Precision redefined

Real-Time Monitoring: AI systems can monitor and analyse data in real-time, providing an instantaneous and comprehensive view of lab processes. This facilitates early detection of anomalies and deviations, allowing for immediate corrective actions.

Predictive Analytics: By leveraging historical data, AI can predict potential issues before they occur. This proactive approach enables labs to implement preventive measures, minimising the risk of errors and ensuring consistent quality.

Automation of Routine Tasks: AI excels at automating repetitive and routine tasks, freeing up human resources for more complex and creative endeavours. This not only increases efficiency but also reduces the likelihood of human error in quality control processes.

Enhanced Data Analysis: The power of AI lies in its ability to analyse vast datasets quickly and accurately. This capability is invaluable in quality control, where precise analysis is paramount for ensuring the reliability of results.


Future-proofing lab operations with AI

As we embrace the current wave of AI applications in quality control, it’s crucial to consider how these technologies can future-proof lab operations and inspire innovation. Integrating AI-driven technologies like machine learning algorithms, robotic process automation, and advanced analytics positions laboratories at the forefront of scientific advancement. Imagine a future where AI not only optimises existing processes but also catalyses the development of novel methodologies and approaches, pushing the boundaries of what is possible in scientific research.


Explore AI for your lab

In the race toward scientific excellence, laboratories cannot afford to overlook the transformative potential of AI in quality control. The possibilities are vast, and the benefits are tangible. To unlock the full spectrum of AI-driven innovations, labs must explore and embrace these technologies actively. The lab of the future is not a distant vision; it is a reality that can be shaped today through the strategic integration of AI in quality control processes.

With more laboratories embarking on the journey toward AI-driven quality control, the call to action is clear – explore the possibilities, discover the potential, and redefine the future of your lab.


To take the first step towards integrating AI into your quality control processes, engage with leading experts and solution providers. The evolution of laboratory operations awaits, and AI is the key to unlocking unparalleled advancements in quality control and scientific discovery.


The Efficiency and Cost Benefits of an Innovative UV-Vis Spectrophotometer

UV-Vis spectroscopy is a mature technology used to analyse, characterise, and quantify pharmaceutical and biological samples such as active pharmaceutical ingredients, DNA/RNA, and proteins for many decades. The use of UV-Vis has been limited by the workflow needed to make these measurements efficiently. The recent advances in UV-Vis spectroscopy focus on enhancing laboratory productivity, offering ease of use, and providing multiple accessories designed specifically for application needs.

Pharmaceutical and biopharmaceutical materials have become more sophisticated in life science research across fields (such as cancer research, drug development, vaccines, and quality control in regulated environments). The technology used for the analysis should evolve, too.

This webinar will highlight the benefit of the new Agilent Cary 3500 Flexible UV-Vis spectrophotometer and its capabilities in improving workflows in the pharmaceutical industry.



Geethika Weragoda
Application Scientist
Agilent Technologies, Australia


Register and watch on demand >


Rapid QC Tablet Testing with Transmission Raman Spectroscopy

The Agilent TRS100 Raman system is ideal for fast assay of tablets, capsules, and other dosage forms. Transmission Raman technology from Agilent enables simple method-development and deployment in QC applications. It is easy to implement in analytical laboratories and production areas, and has regulatory approvals for content uniformity (CU), assay, and identification (ID) applications. This online seminar provides a comprehensive introduction to the Transmission Raman technology and the Agilent TRS100 Raman system in the pharmaceutical quality-control applications.



Yanqia Wang, PhD, Application Engineer, Molecular Spectroscopy, Agilent Technologies, Inc.

Dr. Yanqia Wang started working for Agilent Technologies Inc. as a FTIR application Engineer in 2013, providing pre-&post-sale application support. The products he covers from Bench-top FTIR microscopes to various Mobile FTIR spectrometers. Dr. Wang received his PhD of analytical chemistry from Duke University in 2004, doing dynamic IR spectroscopy research. Then he joined Fitzpatrick Center for Photonics at Duke University, doing Tissue Raman spectrometer instrumentation. Since 2007, Dr. Wang worked for Avery Dennison Corp. as a spectroscopist, providing molecular analytical support to the research & development.


Register Here >


Quality Control | Dissolution Testing

Drug dissolution testing provides necessary in vitro drug release information for pharmaceutical manufacturing quality control, making it a critical tool for performance characterization of diverse dosage forms. Agilent offers pharmaceutical dissolution testing products for product formulation and other applications.



Merits of Automated Sampling in Dissolution Testing

Technical Overview

Dissolution Systems Source Book


Quality Control | Residual Solvent Testing

Residual solvent impurities in pharmaceuticals are trace amounts of volatile organic compounds used in drug production that remain in the final drug product. Strict regulations require close monitoring on the presence of residual solvent, as even trace amounts can impact drug safety and efficacy.



Satisfy Requirements for Residual Solvent Analysis


Residual Solvents Analysis Using an Agilent Intuvo 9000 GC with 8697 Headspace Sampler

Application Note

Analysis of USP Method <467> 

Application Note

Quality Control | Elemental Impurities

With increasing awareness of the potential harmful effects of inorganic contaminants, regulatory organizations have provided new guidelines recommending analytical techniques, such as ICP-OES and ICP-MS, to monitor elemental impurities. Agilent offers integrated solution for confident elemental impurities testing.



USP <232>/<233> and ICH Q3D Elemental Impurities Analysis by ICP-OES

Application Note

USP <232>/<233> and ICH Q3D Elemental Impurities Analysis: Agilent’s ICP-MS solution

White Paper

Support for 21 CFR Part 11 and Annex 11 Compliance: SDA Module for Agilent ICP-MS MassHunter Software

White Paper

Simplified QC for Pharmaceutical Elemental Impurity Analysis


Quality Control | Nitrosamine Mutagenic Impurities

Several drug products were recently recalled due to the presence of unacceptable amounts of mutagenic nitrosamine impurities. Chemetrix offers relevant GC/MS, LC/MS and high-throughput MS-based analytical technologies to accurately detect and quantify trace mutagenic and genotoxic impurities in drug products.



Nitrosamine Impurities Application Guide

Application Guide

Determination of Nitrosamine Impurities Using the Ultivo Triple Quadrupole LC/MS

Application Note

Quantification of Nitrosamine Impurities in Metformin Using Agilent GC/MS/MS Instrumentation

Application Note

Determine Nitrosamines Using LC/MS in Metformin-Based Drugs

Application Note

Determination of a Genotoxic NDMA Impurity Using the High-Resolution Agilent 6546 LC/Q-TOF in Ranitidine

Application Note

Quality Control | Extractables & Leachables

Extractables and leachables (E&Ls) analysis is challenging and requires complete confidence in the results to ensure regulatory compliance. No single analytical tool can analyze all E&Ls; we offer diverse analytical technologies and expertise for the accurate identification and quantification of potential E&Ls.



Analysis of Extractable/Leachable Compounds from Generic Liquid Drug Formulations Using GC/MSD Systems

Application Note

Analysis of Extractable and Leachable (E&L) Compounds Using a Low-Energy EI-Capable High-Resolution Accurate Mass GC/Q-TOF

Application Brief